Abstract submission guideline

For any questions regarding your abstract submission, please contact maxime.sartori@chu-lille.fr

The abstract submission procedure will remain operational until June 7, 2022 (23:59 CEST)


Please note the submission rules before submitting an abstract:

  • Make sure your abstract follows the guidelines for Abstract content and format (see below)
  • Abstracts need to be submitted via the online submission portal by the deadline of June 7, 2022 (23:59, CEST). Abstracts submitted by post, fax or email will not be considered.
  • The submitting author is required to ensure that all co-authors are aware of the content of the abstract before submission. 
  • Submission of an abstract automatically implies acknowledgement of the submitting author that the work described was conducted in accordance with current ethical standards and regulations in medical research.
  • Abstracts should be submitted and presented in English.
  • Changes to an abstract will not be permitted once the submission deadline has passed. 
  • Abstracts will be reviewed by the Scientific Program Committee. Abstracts which include ethical concerns, do not meet scientific standards or include work not sufficiently relevant for FTD can be rejected. Notification regarding abstract acceptance and scheduling will be sent to the submitting author by email.
  • All abstracts accepted for presentation will be published via the Conference website.
  • Please note that the presenting author is not automatically registered by submitting an abstract.

Non-registered authors will not be permitted to present their work at the conference. Only accepted abstracts with a presenting author registered with will be included for publication.


Content and Format

  • Abstracts will be evaluated by the Local Organising Committee and the Scientific Program Committee.
  • Abstracts must be allocated to a specific category. Please select the category from the list below that best matches the focus of your study. This will be used to organise the abstracts for the purpose of review and presentation.

However, the reviewers may assign the abstract to a different category that they feel is more appropriate. 

- Epidemiology
- Clinics
- Language and cognition
- Behavior
- Biomarkers
- Genetics
- Clinical trials and management
- Neuropathology
- Bioinformatics
- Basic science, cellular and molecular biology

  • The abstract should be no more than 250 words in length and should be divided into several paragraphs as shown below: 

- State of the art
- Methodology
- Results
- Conclusion

  • No tables or images are allowed in the abstract.
  • If references are essential, they should be within the text using the format: (Murphy et al. BJU Int 2005; 95 27-30).
  • Required authors’ details:  

First and presenting author: name (last name and first initial), affiliation details (organisation/institution, suburb/city, state and country) - Details such as email and postal address will be requested in the abstract portal

IMPORTANT NOTE: The submitting author must be the presenting author.

  • Co-authors: name (last name and first initial), affiliation details (organisation/institution, suburb/city, state and country)


Previous page: Abstracts Next page: Abstract submission for Hot Topics